酵素結合免疫吸着測定法の世界市場レポート 2025年

酵素結合免疫吸着測定法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で38億8,000万米ドルに成長します。予測期間の成長は、個別化医療への需要の高まり、高齢者人口の増加、早期発見の重視、ヘルスケアサービスへのアクセスの改善、慢性疾患モニタリングのニーズの高まりに起因しています。予測期間における主な動向としては、技術の進歩、ポイントオブケア検査に対する需要の高まり、応用領域の拡大、ハイスループットスクリーニングの採用、デジタルELISAの出現などが挙げられます。

感染性疾患の発生率の増加は、酵素結合免疫吸着測定法（ELISA）検査市場の成長を促進すると予想されます。細菌、ウイルス、真菌、寄生虫などの病原性微生物によって引き起こされる感染症は、個人間で蔓延し、さまざまな身体系に影響を及ぼす可能性があります。これらの疾患の増加は、世界の旅行の増加や、感染制御の取り組みを複雑にしている抗菌薬耐性の問題の増大などの要因によるものです。ELISA検査は、感染症に関連する特定の抗原や抗体を正確に検出・定量できるため、感染症の管理に有用であり、診断、病気の進行のモニタリング、治療効果の評価に役立っています。例えば、2024年2月、スイスを拠点とする公衆衛生機関である世界保健機関（WHO）は、2023年に欧州地域で5万8,114件の麻疹患者が記録されたと報告し、これは2022年の941件から大幅に増加しました。このように感染症の発生率が上昇していることが、ELISA検査市場の成長を促進しています。

ELISA検査市場の主要企業は、診断精度を向上させ、多様な研究および臨床要件に対応するために、新規ELISAキットなどのイノベーションによって製品提供を進めています。これらの先進的なELISAキットは、バイオマーカーの検出と定量に精度、感度、使いやすさを向上させています。例えば、米国の製薬会社チャールズ・リバー・ラボラトリーズは2023年2月、CHOベースのバイオ治療薬に残存する宿主細胞タンパク質（HCP）を検出・定量するために設計された新規ELISAキットを発売しました。このキットは、特定病原体不検出（SPF）鶏卵由来の鳥類免疫グロブリンY（IgY）抗体を使用しており、0.1ng/mLという低い検出下限値と90％の抗体カバー率で、感度と特異性の向上を実現しています。この技術革新は、バイオ医薬品開発における品質管理を強化し、新しい治療法の安全性と有効性を確保することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界酵素結合免疫吸着測定法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の酵素結合免疫吸着測定法市場：成長率分析
• 世界の酵素結合免疫吸着測定法市場の実績：規模と成長, 2019-2024
• 世界の酵素結合免疫吸着測定法市場の予測：規模と成長, 2024-2029, 2034F
• 世界酵素結合免疫吸着測定法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の酵素結合免疫吸着測定法市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接酵素免疫測定（ELISA）
• サンドイッチ酵素免疫測定（ELISA）
• 間接酵素免疫測定（ELISA）
• 多項目・ポータブルな酵素免疫測定（ELISA）
• 競合酵素免疫測定（ELISA）
• 世界の酵素結合免疫吸着測定法市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫学
• 炎症
• 感染症
• がん
• タンパク質定量
• その他の用途
• 世界の酵素結合免疫吸着測定法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診断センター
• 調査室
• その他のエンドユーザー
• 世界の酵素結合免疫吸着測定法市場、直接酵素免疫測定法（ELISA）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルステップ直接ELISA
• 競合的直接ELISA
• 定量的直接ELISA
• 定性直接ELISA
• 世界の酵素結合免疫吸着測定法市場サンドイッチ酵素免疫測定（ELISA）のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 2ステップサンドイッチELISA
• ワンステップサンドイッチELISA
• 定量サンドイッチELISA
• 定性サンドイッチELISA
• 世界の酵素結合免疫吸着測定法市場間接酵素免疫測定（ELISA）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準間接ELISA
• 競合的間接ELISA
• 定量的間接ELISA
• 定性間接ELISA

第7章 地域別・国別分析

• 世界の酵素結合免疫吸着測定法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の酵素結合免疫吸着測定法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 酵素結合免疫吸着測定法市場：競合情勢
• 酵素結合免疫吸着測定法市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Tecan Group Ltd.
• GenScript Biotech Corporation
• Promega Corporation
• Abcam plc
• R&D Systems Inc.
• Sino Biological Inc.
• OriGene Technologies Inc.
• RayBiotech Inc.
• Santa Cruz Biotechnology Inc.
• AnaSpec Inc.
• Biomatik
• Arigo Biolaboratories Corp.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 酵素結合免疫吸着測定法市場2029：新たな機会を提供する国
• 酵素結合免疫吸着測定法市場2029：新たな機会を提供するセグメント
• 酵素結合免疫吸着測定法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Enzyme-linked immunosorbent assay (ELISA) testing is a widely used laboratory technique designed to detect and quantify specific proteins, antigens, or antibodies in a sample. The method involves immobilizing an antigen or antibody on a solid surface, typically a microplate, and then using enzyme-linked antibodies or antigens to bind to the target molecule.

The main types of ELISA testing include direct enzyme-linked immunosorbent assay (ELISA), sandwich enzyme-linked immunosorbent assay (ELISA), indirect enzyme-linked immunosorbent assay (ELISA), multiple and portable enzyme-linked immunosorbent assays (ELISA), and competitive enzyme-linked immunosorbent assays (ELISA). Direct enzyme-linked immunosorbent assay (ELISA) involves directly immobilizing an antigen on a solid surface. This method can be used for applications in immunology, inflammation, infectious diseases, cancer, protein quantitation, and other areas, serving various end users such as hospitals and diagnostic centers, research laboratories, and more.

The enzyme-linked immunosorbent assay testing market research report is one of a series of new reports from The Business Research Company that provides enzyme-linked immunosorbent assay testing market statistics, including enzyme-linked immunosorbent assay testing industry global market size, regional shares, competitors with an enzyme-linked immunosorbent assay testing market share, detailed enzyme-linked immunosorbent assay testing market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme-linked immunosorbent assay testing industry. This enzyme-linked immunosorbent assay testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzyme-linked immunosorbent assay testing market size has grown strongly in recent years. It will grow from $2.85 $ billion in 2024 to $3.04 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the prevalence of chronic diseases, increased funding and emphasis on biomedical research, approval of ELISA tests by regulatory bodies, government initiatives, and health awareness programs.

The enzyme-linked immunosorbent assay testing market size is expected to see strong growth in the next few years. It will grow to $3.88 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for personalized medicine, a growing geriatric population, greater emphasis on early detection, improved access to healthcare services, and a and a growing need for chronic disease monitoring. Major trends in the forecast period include technological advancements, growing demand for point-of-care testing, expanding application areas, the adoption of high-throughput screening, and the emergence of digital ELISA.

The increasing incidence of infectious disorders is expected to drive growth in the enzyme-linked immunosorbent assay (ELISA) testing market. Infectious disorders, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, can spread between individuals and affect various body systems. The rise in these disorders is due to factors such as increased global travel and the growing issue of antimicrobial resistance, which complicates infection control efforts. ELISA testing is valuable for managing infectious disorders as it enables precise detection and quantification of specific antigens or antibodies associated with infections, aiding in diagnosis, monitoring disease progression, and assessing treatment effectiveness. For example, in February 2024, the World Health Organization, a Switzerland-based public health organization, reported that 58,114 cases of measles were recorded in the European Region in 2023, a significant increase from 941 cases in 2022. This rising incidence of infectious disorders is thus propelling the growth of the ELISA testing market.

Leading companies in the ELISA testing market are advancing their product offerings with innovations such as novel ELISA kits to enhance diagnostic accuracy and address diverse research and clinical requirements. These advanced ELISA kits offer improved accuracy, sensitivity, and usability for detecting and quantifying biomarkers. For instance, in February 2023, Charles River Laboratories, a US-based pharmaceutical firm, launched a novel ELISA kit designed for detecting and quantifying residual host cell proteins (HCP) in CHO-based biotherapeutics. This kit employs avian immunoglobulin Y (IgY) antibodies derived from specific pathogen-free (SPF) chicken eggs, achieving enhanced sensitivity and specificity with detection limits as low as 0.1 ng/mL and 90% antibody coverage. This innovation aims to enhance quality control in biopharmaceutical development, ensuring the safety and efficacy of new therapies while offering flexibility for client use, either independently or with support from Charles River's experts.

In February 2024, Dyadic International Inc., a biotechnology company based in the US, formed a partnership with Cygnus Technologies to provide a C1 host cell protein (HCP) enzyme-linked immunosorbent assay designed to enhance quality assurance in biomanufacturing. This collaboration centers on quantifying host cell proteins derived from Dyadic's proprietary C1 cells, which utilize the filamentous fungus Thermothelomyces heterothallica. Cygnus Technologies LLC is also a biopharmaceutical company based in the US.

Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc, Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio

North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2023. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzyme-linked immunosorbent assay testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enzyme-linked immunosorbent assay testing market consists of revenues earned by entities providing services such as diagnostic testing, research and development, detection of antibodies, and vaccine development. The market value includes the value of related goods sold by the service provider or included within the service offering. The enzyme-linked immunosorbent assay testing market also includes sales of ELISA kits, control samples, inhibitor assays, and other consumables such as microplate readers, washers, and automated ELISA systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzyme-Linked Immunosorbent Assay Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme-linked immunosorbent assay testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme-linked immunosorbent assay testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzyme-linked immunosorbent assay testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA); Sandwich Enzyme-Linked Immunosorbent Assay (ELISA); Indirect Enzyme-Linked Immunosorbent Assay (ELISA); Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA); Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
• 2) By Application: Immunology; Inflammation; Infectious Diseases; Cancer; Protein Quantitation; Other Applications
• 3) By End-User: Hospitals And Diagnostic Centers; Research Laboratories; Other End-Users
• Subsegments:
• 1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA; Competitive Direct ELISA; Quantitative Direct ELISA; Qualitative Direct ELISA
• 2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA; One-Step Sandwich ELISA; Quantitative Sandwich ELISA; Qualitative Sandwich ELISA
• 3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA; Competitive Indirect ELISA; Quantitative Indirect ELISA; Qualitative Indirect ELISA
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzyme-Linked Immunosorbent Assay Testing Market Characteristics

3. Enzyme-Linked Immunosorbent Assay Testing Market Trends And Strategies

4. Enzyme-Linked Immunosorbent Assay Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Enzyme-Linked Immunosorbent Assay Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Enzyme-Linked Immunosorbent Assay Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Enzyme-Linked Immunosorbent Assay Testing Market Growth Rate Analysis
• 5.4. Global Enzyme-Linked Immunosorbent Assay Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Enzyme-Linked Immunosorbent Assay Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Enzyme-Linked Immunosorbent Assay Testing Total Addressable Market (TAM)

6. Enzyme-Linked Immunosorbent Assay Testing Market Segmentation

• 6.1. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Enzyme-Linked Immunosorbent Assay (ELISA)
• Sandwich Enzyme-Linked Immunosorbent Assay (ELISA)
• Indirect Enzyme-Linked Immunosorbent Assay (ELISA)
• Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA)
• Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
• 6.2. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunology
• Inflammation
• Infectious Diseases
• Cancer
• Protein Quantitation
• Other Applications
• 6.3. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Diagnostic Centers
• Research Laboratories
• Other End-Users
• 6.4. Global Enzyme-Linked Immunosorbent Assay Testing Market, Sub-Segmentation Of Direct Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Step Direct ELISA
• Competitive Direct ELISA
• Quantitative Direct ELISA
• Qualitative Direct ELISA
• 6.5. Global Enzyme-Linked Immunosorbent Assay Testing Market, Sub-Segmentation Of Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Two-Step Sandwich ELISA
• One-Step Sandwich ELISA
• Quantitative Sandwich ELISA
• Qualitative Sandwich ELISA
• 6.6. Global Enzyme-Linked Immunosorbent Assay Testing Market, Sub-Segmentation Of Indirect Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Indirect ELISA
• Competitive Indirect ELISA
• Quantitative Indirect ELISA
• Qualitative Indirect ELISA

7. Enzyme-Linked Immunosorbent Assay Testing Market Regional And Country Analysis

• 7.1. Global Enzyme-Linked Immunosorbent Assay Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Enzyme-Linked Immunosorbent Assay Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market

• 8.1. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enzyme-Linked Immunosorbent Assay Testing Market

• 9.1. China Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 9.2. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enzyme-Linked Immunosorbent Assay Testing Market

• 10.1. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enzyme-Linked Immunosorbent Assay Testing Market

• 11.1. Japan Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 11.2. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enzyme-Linked Immunosorbent Assay Testing Market

• 12.1. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market

• 13.1. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enzyme-Linked Immunosorbent Assay Testing Market

• 14.1. South Korea Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 14.2. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market

• 15.1. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 15.2. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enzyme-Linked Immunosorbent Assay Testing Market

• 16.1. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enzyme-Linked Immunosorbent Assay Testing Market

• 17.1. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enzyme-Linked Immunosorbent Assay Testing Market

• 18.1. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enzyme-Linked Immunosorbent Assay Testing Market

• 19.1. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enzyme-Linked Immunosorbent Assay Testing Market

• 20.1. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market

• 21.1. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 21.2. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enzyme-Linked Immunosorbent Assay Testing Market

• 22.1. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enzyme-Linked Immunosorbent Assay Testing Market

• 23.1. North America Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 23.2. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enzyme-Linked Immunosorbent Assay Testing Market

• 24.1. USA Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 24.2. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enzyme-Linked Immunosorbent Assay Testing Market

• 25.1. Canada Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 25.2. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enzyme-Linked Immunosorbent Assay Testing Market

• 26.1. South America Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 26.2. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enzyme-Linked Immunosorbent Assay Testing Market

• 27.1. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enzyme-Linked Immunosorbent Assay Testing Market

• 28.1. Middle East Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 28.2. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enzyme-Linked Immunosorbent Assay Testing Market

• 29.1. Africa Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 29.2. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enzyme-Linked Immunosorbent Assay Testing Market Competitive Landscape And Company Profiles

• 30.1. Enzyme-Linked Immunosorbent Assay Testing Market Competitive Landscape
• 30.2. Enzyme-Linked Immunosorbent Assay Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Enzyme-Linked Immunosorbent Assay Testing Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. PerkinElmer Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Tecan Group Ltd.
• 31.5. GenScript Biotech Corporation
• 31.6. Promega Corporation
• 31.7. Abcam plc
• 31.8. R&D Systems Inc.
• 31.9. Sino Biological Inc.
• 31.10. OriGene Technologies Inc.
• 31.11. RayBiotech Inc.
• 31.12. Santa Cruz Biotechnology Inc.
• 31.13. AnaSpec Inc.
• 31.14. Biomatik
• 31.15. Arigo Biolaboratories Corp.

32. Global Enzyme-Linked Immunosorbent Assay Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enzyme-Linked Immunosorbent Assay Testing Market

34. Recent Developments In The Enzyme-Linked Immunosorbent Assay Testing Market

35. Enzyme-Linked Immunosorbent Assay Testing Market High Potential Countries, Segments and Strategies

• 35.1 Enzyme-Linked Immunosorbent Assay Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Enzyme-Linked Immunosorbent Assay Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Enzyme-Linked Immunosorbent Assay Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer